<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03992560</url>
  </required_header>
  <id_info>
    <org_study_id>1.1</org_study_id>
    <nct_id>NCT03992560</nct_id>
  </id_info>
  <brief_title>A Prospective Randomised Multi-centre Trial Comparing cArdiac MRI Guided CRT Versus Conventional CRT Implantation in Patients With Ischaemic Cardiomyopathy</brief_title>
  <acronym>TACTIC CRT</acronym>
  <official_title>A Prospective Randomised Multi-centre Trial Comparing cArdiac MRI Guided CRT Versus Conventional CRT Implantation in Patients With Ischaemic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether MRI guided CRT implantation (using Siemen's
      software prototype) is superior to standard treatment in terms of CRT response. Data will be
      collected at enrolment, implant, pre-discharge, 6 weeks and 6 months. The total duration of
      the investigation will be 6 months.

      The primary endpoint will be assessed by calculating the difference in the proportion of
      responders (&gt;15% reduction in end systolic volume derived from 2-dimensional transthoracic
      echocardiogram at 6 months post CRT implant).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Anticipated">July 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>&gt;15% reduction in end systolic volume</measure>
    <time_frame>6 months</time_frame>
    <description>&gt;15% reduction in end systolic volume derived from 2-dimensional transthoracic echocardiogram at 6 months post CRT implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>5% absolute increase in left ventricular ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>5% absolute increase in left ventricular ejection fraction as derived from 2D echocardiogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&gt;10% reduction in end diastolic volume</measure>
    <time_frame>6 months</time_frame>
    <description>&gt;10% reduction in end diastolic volume as derived from 2D echocardiogram</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">218</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Standard CRT implantation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI guided CRT implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Guide CRT Software Prototype</intervention_name>
    <description>The medical device in the trial is a software programme that allows image fusion of previously acquired MRI images with real-time X-Ray fluoroscopic images in the cardiac catheter laboratory. We are able to use the MRI information to assess the best location to place the left ventricular lead for a CRT device and then superimpose this location onto the real-time X-Ray fluoroscopic images during the left ventricular lead implantation</description>
    <arm_group_label>MRI guided CRT implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18yrs of age

          -  Standard indication for CRT-P or CRT-D according to European Society of Cardiology
             (ESC)/European Heart Rhythm (EHRA) guidelines.1

          -  Stable on optimal medical therapy for at least 3 months

          -  Ischaemic aetiology

          -  Patients with atrial fibrillation can be included

        Exclusion Criteria:

          -  Any contraindication to pacing /implantable cardioverter-defibrillator (ICD) implant

          -  Requirement for endocardial pacing

          -  Contraindication to gadolinium contrast enhanced cardiac Magnetic Resonance (MR)
             scanning

          -  Significant claustrophobia

          -  Significant renal impairment with estimated glomerular filtration rate (eGFR) &lt;30
             mL/min/1.73m2

          -  Existing pacemaker or ICD system or extraction of a CRT system within the last 6
             months

          -  Participation in other studies with active treatment/ investigational arm

          -  Pregnant or planning to become pregnant in the next 7 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Guys and St Thomas NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Humra Chadwick</last_name>
      <phone>02071887188</phone>
      <phone_ext>56217</phone_ext>
      <email>humra.chadwick1@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Aldo Rinaldi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>June 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

